Q108U0 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigko7hhksmaj5xbha7kyvhbxg75qujs2x4uf3mbcd7qjdbsgsazmu/metadata.json
IPFS of structure file: 
bafybeiadafi3ebe6dpbtdlej7pmdjjorlf67i47jl6b73r5ngwv5ughi4a/AF-Q108U0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xb3c0C983Fc44934AC589D7131C08a72544EBB92E
First NFT owner address (bech32): 
genesis1k0qvnqlugjf543vf6uf3cz98y4zwhwfw5hvdqx
Current NFT ID #58973 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
58973
Accession (UniProt):
Q108U0
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Loxodonta africana

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q108U0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q108U0|CFTR_LOXAF Cystic fibrosis transmembrane conductance regulator OS=Loxodonta africana OX=9785 GN=CFTR PE=3 SV=1 MQKSPLERASVISKLFFSWPGPILRKGYRQHLKLSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFVFYGILLYLGEVTKAVQPLLLGRIIASYDPDNKVERSIAIYLAIGLCLLFIVRTLLLHPAIFGLHHMGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVTLLMGLIWDLLQASAFCGLAFLIIVALGQAGLGRMMMKYRDKRAGKINERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQIELRLTRKAAYVRYFNSAAFFFSGFFVVFLSVLPYAMLKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTDVVMENVTAFWEEGFGELFEKAKQNNNNREISNGDNSLFFSNFSLLGAPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQTLRPDFSSELMGYDSFDQFSAERRNSILTETLRRFSLEGDTVSWNETKKQSFKQAGEFGEKRKNSILNSINSIRKFSVVQKTPLQMNGIDEDSDEPLERRLSLVPDSEQGEAILPRSNVINTGPTFQRRRRQSVLNLMTRPSINQGQNIHRRTAASARKMSLAPQANLTEMDIYSRRLSQDSGLEISEEINEEDLKECFFDDVENMPPVTTWNTYLRYVTVHKSLIFVLIWCLVVFLAEVAVSLVVLYLLRTSSLQDKGNNTTVNANSSYGVIVTNTSSYYLLYIYVGIADSLFALAIFRGLPLVHTLIKVSKTLHHKMLRSILQAPMSTFNTLKAGRILNRFSKDIAILDDLLPLTMFDFIQLLLIVIGAVVVVSVLQPYIFLATVPVIAAFIILRAYFLHTSQQLKQLESEARSPIFTHLVTSVKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEIIFVIFFIAVTFVSILTTGEGEGTIGIILTLAMNIMNTLQWAVNSSIDVDSLMRSVSRIFKFIDMPTEESKPAKSVKPPKDGQLSKVMIIENQHVKKDYNWPSGGHMTVKDLTAKYIDGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQCSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGYVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPITYQIIRRTLKQAFADCTVILCEHRVEAMLECQQFLVIEENTVRQYDSIQKLLNEKSLFRQAISPLDRMKLLPHRNSSRHRSRSQIAALKEETEEEVQETRL